AlveoliX AG
PrivateLast Round
Grant
Oct 1, 2024
Total Funding Raised
$2.07M
Company Overview
AlveoliX AG operates in Healthcare & Life Sciences and is based in Bern. Its latest recorded funding round was a Grant round in October 2024.
AlveoliX AG is a life sciences platforms and tools company that provides organ-on-chip in-vitro solutions aimed at improving preclinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlveoliX AG Comparables
Compare AlveoliX AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiomimX | 89% | |
| Cellbox Labs | 89% | |
| AIM Biotech | 88% |
For institutional investors. Book with your work email.
AlveoliX AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2024 | ||||
| Grant | Jun 14, 2022 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Mar 19, 2019 | ||||
| Grant | Feb 1, 2016 | ||||
Grant | Jan 13, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlveoliX AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| European Commission | Grant |
| Rannís - The Icelandic Centre for Research | Grant |
| Eurostars SME programme | Grant |
| Bern Economic Development Agency | Grant |
| Innosuisse | Grant |
| Venture Kick | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors grew 88% MoM, from 747 to 1.4K.
- Jul 19, 2025
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
AlveoliX AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlveoliX AG's valuation, stock price, and market status.
Is AlveoliX AG a public or private company?
AlveoliX AG is a private company.
What is the current stock price of AlveoliX AG?
AlveoliX AG is a private company, so its shares have no public market price. Caplight tracks AlveoliX AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlveoliX AG worth (valuation)?
Valuation information for AlveoliX AG is not publicly available.
Can I buy AlveoliX AG stock?
AlveoliX AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlveoliX AG's last funding round?
AlveoliX AG's most recent funding round was Grant on October 1, 2024.
Who are the main investors in AlveoliX AG?
Key investors in AlveoliX AG include Eureka Network, European Commission, Rannís - The Icelandic Centre for Research, Eurostars SME programme, Bern Economic Development Agency.
Will AlveoliX AG IPO soon?
No public IPO plans have been announced for AlveoliX AG.
How can I track AlveoliX AG secondary market activity?
Caplight tracks bids, offers, and trades in AlveoliX AG's shares on secondary markets.